SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Kirk's Market Thoughts
COHR 185.70+2.2%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kirk © who wrote (1224)5/12/2014 5:15:38 PM
From: Brian Sullivan1 Recommendation

Recommended By
Kirk ©

  Read Replies (1) of 26729
 
Morningstar upgrades Agilent - A

quotes.morningstar.com

Spun out of Hewlett-Packard in 1999, Agilent has evolved into a global measurement giant. Through a series of acquisitions and divestitures, most recently in the life sciences arena, Agilent has transformed from a small technology startup into a leading health care firm. Today, Agilent uses its unmatched technological expertise and global reach to serve a broad base of customers across the communications, electronics, life sciences, and chemical analysis industries. Agilent will spin off its electronics segment in late 2014 under the name Keysight Technologies.

...

We’re increasing our fair value estimate for Agilent to $62 per share from $49 after boosting our margin expansion assumptions. Our model still incorporates nearly 6% annualized growth over the next five years, but we think organic earnings can grow nearly 9% over the same time frame thanks to operating leverage and efficiency efforts. We previously forecast earnings growth roughly in line with top-line performance. Our valuation implies a price to earnings multiple of 20.

Our 6% annualized growth results from double-digit growth in the Agilent’s life sciences division offsetting further weakness in the electronics measurement segment. We expect solid mid-single digit growth in the chemical analysis business as the market continues to recover from recent customer budget constraints. A rising contribution from emerging markets should also help boost Agilent’s overall growth trajectory.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News